GORDON CARL L bought SCTX

July 27, 2026 · Form 4 insider transaction

GORDON CARL L bought 1,000,000 shares of Scribe Therapeutics Inc. at $15.00 per share, a transaction worth $15.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,000,000
Price
$15.00
Total value
$15.00M
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJuly 27, 2026
Filing dateJuly 29, 2026
Shares owned after1,348,825
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects shares of the Issuer's Common Stock purchased in the Issuer's initial public offering.; The shares are held directly by OrbiMed Private Investments VIII, LP ("OPI VIII"). OrbiMed Capital GP VIII LLC ("GP VIII") is the general partner of OPI VIII. OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VIII. By virtue of such relationships, GP VIII and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VIII and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VIII.; Each of the Reporting Person, OrbiMed Advisors and GP VIII disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his or its pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Person, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

View the original Form 4 on SEC EDGAR